Is 2-Benzothiazolamine, 6-(trifluoromethoxy)- Safe in Breastfeeding

I am a breastfeeding mother and i want to know if it is safe to use 2-Benzothiazolamine, 6-(trifluoromethoxy)-? Is 2-Benzothiazolamine, 6-(trifluoromethoxy)- safe for nursing mother and child? Does 2-Benzothiazolamine, 6-(trifluoromethoxy)- extracts into breast milk? Does 2-Benzothiazolamine, 6-(trifluoromethoxy)- has any long term or short term side effects on infants? Can 2-Benzothiazolamine, 6-(trifluoromethoxy)- influence milk supply or can 2-Benzothiazolamine, 6-(trifluoromethoxy)- decrease milk supply in lactating mothers?

• DrLact safety Score for 2-Benzothiazolamine, 6-(trifluoromethoxy)- is 5 out of 8 which is considered Unsafe as per our analyses.
• A safety Score of 5 indicates that usage of 2-Benzothiazolamine, 6-(trifluoromethoxy)- may cause serious side effects in breastfed baby.
• Our study of different scientific research indicates that 2-Benzothiazolamine, 6-(trifluoromethoxy)- may cause moderate to high side effects or may affect milk supply in lactating mother.
• Our suggestion is to use safer alternate options rather than using 2-Benzothiazolamine, 6-(trifluoromethoxy)- .
• It is recommended to evaluate the advantage of not breastfeeding while using 2-Benzothiazolamine, 6-(trifluoromethoxy)- Vs not using 2-Benzothiazolamine, 6-(trifluoromethoxy)- And continue breastfeeding.
• While using 2-Benzothiazolamine, 6-(trifluoromethoxy)- Its must to monitor child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
• Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Treatment of amyotrophic lateral sclerosis.

Limited information indicates that maternal doses of 2-Benzothiazolamine, 6-(trifluoromethoxy)- up to 100 mg daily produce low levels in milk and would not be expected to cause any adverse effects in breastfed infants, especially if the infant is older than 2 months. Until more data are available, use 2-Benzothiazolamine, 6-(trifluoromethoxy)- with caution, particularly when breastfeeding a newborn.